BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26816829)

  • 21. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
    D'Andrea D; Matin S; Black PC; Petros FG; Zargar H; Dinney CP; Cookson MS; Kassouf W; Dall'Era MA; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; Sridhar SS; North S; Barocas DA; Lotan Y; Stephenson AJ; van Rhijn BW; Spiess PE; Daneshmand S; Shariat SF
    BJU Int; 2021 May; 127(5):528-537. PubMed ID: 32981193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic Ultrasound-guided Fine Needle Aspiration for the Diagnosis of Duodenal Stenosis Due to Urothelial Carcinoma.
    Motoo I; Ando T; Mihara H; Tanaka S; Nanjo S; Kajiura S; Fujinami H; Takahashi K; Yasuda I
    Intern Med; 2021 Mar; 60(5):719-724. PubMed ID: 32963164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging.
    Rouvière O; Cornelis F; Brunelle S; Roy C; André M; Bellin MF; Boulay I; Eiss D; Girouin N; Grenier N; Hélénon O; Lapray JF; Lefèvre A; Matillon X; Ménager JM; Millet I; Ronze S; Sanzalone T; Tourniaire J; Rocher L; Renard-Penna R;
    Eur Radiol; 2020 Apr; 30(4):2103-2114. PubMed ID: 31900706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma.
    Kim SH; Song MK; Joung JY; Chung J; Lee KH; Seo HK
    Investig Clin Urol; 2019 Nov; 60(6):432-442. PubMed ID: 31692890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?
    Goldberg H; Cheung DC; Chandrasekar T; Klaassen Z; Wallis CJD; Kulkarni GS; Sayyid R; Evans A; Masoomian M; Bapat B; van der Kwast T; Hamilton RJ; Zlotta A; Fleshner N
    Can Urol Assoc J; 2019 Sep; 13(9):E292-E299. PubMed ID: 30763230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robot-assisted nephroureterectomy: current perspectives.
    Teo XL; Lim SK
    Robot Surg; 2016; 3():37-48. PubMed ID: 30697554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex-vivo Imaging of Upper Tract Urothelial Carcinoma Using Novel pH Low Insertion Peptide (Variant 3), a Molecular Imaging Probe.
    Brito J; Golijanin B; Kott O; Moshnikova A; Mueller-Leonhard C; Gershman B; Andreev OA; Reshetnyak YK; Amin A; Golijanin D
    Urology; 2020 May; 139():134-140. PubMed ID: 30659902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues.
    Sanguedolce F; Cormio L
    Transl Androl Urol; 2018 May; 7(Suppl 2):S248-S251. PubMed ID: 29928626
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
    Momota M; Hatakeyama S; Yamamoto H; Iwamura H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Iwabuchi I; Ogasawara M; Kawaguchi T; Ohyama C
    Oncotarget; 2018 May; 9(33):23047-23057. PubMed ID: 29796171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial.
    van Doeveren T; van Leeuwen PJ; Aben KKH; van der Aa M; Barendrecht M; Boevé ER; Cornel EB; van der Heijden AG; Hendricksen K; Hirdes W; Kooistra A; Kroon B; Leliveld AM; Meijer RP; van Melick H; Merks B; de Reijke TM; de Vries P; Wymenga LFA; Wijsman B; Boormans JL
    Contemp Clin Trials Commun; 2018 Mar; 9():121-129. PubMed ID: 29696234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
    Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
    World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Kodama H; Hatakeyama S; Fujita N; Iwamura H; Anan G; Fukushi K; Narita T; Tanaka T; Kubota Y; Horiguchi H; Momota M; Kido K; Matsumoto T; Soma O; Hamano I; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Sasaki A; Kawaguchi T; Sato M; Ohyama C
    Oncotarget; 2017 Oct; 8(47):83183-83194. PubMed ID: 29137333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors and outcomes of primary transitional cell carcinoma of the ureter: a population-based study.
    Ding T; Zheng Z; Xu R; Zhou C
    Oncotarget; 2017 Sep; 8(39):65983-65996. PubMed ID: 29029487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why are upper tract urothelial carcinoma two different diseases?
    Szarvas T; Módos O; Horváth A; Nyirády P
    Transl Androl Urol; 2016 Oct; 5(5):636-647. PubMed ID: 27785420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary concepts and controversies in the diagnosis and management of urothelial carcinoma.
    Shariat SF; Mathieu R
    Transl Androl Urol; 2016 Oct; 5(5):633-635. PubMed ID: 27785419
    [No Abstract]   [Full Text] [Related]  

  • 36. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
    Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
    World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upper urinary tract disease: what we know today and unmet needs.
    Mathieu R; Bensalah K; Lucca I; Mbeutcha A; Rouprêt M; Shariat SF
    Transl Androl Urol; 2015 Jun; 4(3):261-72. PubMed ID: 26816829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
    Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.